GHRH analog is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-07-26. Numbers and descriptions here follow the published literature rather than marketing material.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, built from 44 amino acids. Its sequence follows the natural human GHRH(1-44) backbone, with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification blocks recognition by dipeptidyl peptidase IV, the enzyme that rapidly truncates the native hormone in circulation. The result is a molecule with a substantially longer plasma residence time than unmodified GHRH, which makes it practical for clinical and laboratory study.
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
Physicochemical behavior is dominated by the peptide backbone. The molecule is hydrophilic and carries a net positive charge near neutral pH, owing to several arginine and lysine residues. In solution it adopts a largely unstructured conformation, and aggregation is a known concern for peptide products of this size. Oxidation of methionine and deamidation of asparagine or glutamine residues are the principal chemical degradation routes. These liabilities shape how the material is formulated, handled, and analyzed, and they explain why lyophilized presentations are common in research settings.
特沙莫瑞林是一种合成肽，其序列与人生长激素释放激素的 44 个氨基酸形式相关。它在 N 端带有反式-3-己烯酰基修饰，这一改动可减缓二肽基肽酶 IV 的降解。该化合物属于生长激素释放激素受体激动剂，可刺激垂体释放生长激素。研究文献通常将其归入合成肽类药物，而非小分子化合物。
监管记录显示，特沙莫瑞林于 2010 年在美国首次获得批准，用于人类免疫缺陷病毒感染相关的脂肪营养不良患者。批准依据来自降低内脏脂肪的临床试验，而非体重或瘦体重的普遍改善。后续出现了不同制剂版本，但其核心适应症保持一致。关于长期心血管结局和死亡率影响，现有证据仍不充分。
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | GHRH receptor agonist |
| Residue count | 44 amino acids | Matches human GHRH(1-44) length |
| N-terminal modification | trans-3-hexenoyl group | Confers resistance to dipeptidyl peptidase IV |
| Appearance | White to off-white powder | Typically supplied lyophilized in a sealed vial |
| Solubility class | Freely soluble in water | Hydrophilic peptide; polar solvent compatible |
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
The peptide is synthesized chemically rather than extracted from biological sources. Solid-phase synthesis builds the chain from the C-terminus toward the N-terminus, after which the hexenoyl group is attached. Purity is typically assessed by high-performance liquid chromatography, and identity is confirmed by mass spectrometry. Regulatory review of the finished product focuses on these analytical controls, since small deviations in sequence or modification can change biological activity. Questions about long-term effects on the pituitary axis remain areas of continued investigation.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone (GHRH) family. Its sequence corresponds to the fully active 44-amino-acid form of human GHRH, with a single structural modification: the addition of a trans-3-hexenoyl group at the N-terminus. That modification is not found in the naturally occurring hormone and was introduced deliberately during development to improve stability against enzymatic degradation. The compound is therefore best described as a stabilized analogue rather than a naturally occurring peptide.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
== Honors and awards == 1971 ACS Award in Chemical Instrumentation 1981 ACS Award in Analytical Chemistry 1984 William H. Nichols Medal 1985 Oesper Award 1985 J. J. Thomson Gold Medal by International Mass Spectrometry Society 1987 Pittsburgh Analytical Chemistry Award 1989 Field and Franklin Award for Mass Spectrometry 1989 University of Naples Gold Medal 1992 Robert Boyle Gold Medal by the Royal Society of Chemistry 1996 Chemical Pioneer Award from the American Institute of Chemists 1997 Bijvoet Medal of the Bijvoet Center for Biomolecular Research. 1999 J. Heyrovsky Medal by the Czech Academy of Sciences 2000 G. Natta Gold Medal by Italian Chemical Society 2001 Torbern Bergman Medal by the Swedish Chemical Society 2003 John B. Fenn Distinguished Contribution in Mass Spectrometry by the American Society for Mass Spectrometry (ASMS) 2004 Lavoisier Medal by the French Chemical Society 2006 Pehr Edman Award by the International Association for Protein Structure 2015 Nakanishi Prize from the American Chemical Society 2019 American Chemical Society designated a National Historic Chemical Landmark in Midland, MI for the demonstration of the first operating GC-MS by Fred McLafferty and Roland Gohlke.
== Side effects == Nausea is a common side effect of intravenous administration and less common in other modes. Antiemetics can be given prior to DHE to counteract the nausea. Risks and contraindications are similar to the triptans. DHE and triptans should never be taken within 24 hours of each other due to the potential for coronary artery vasospasm. DHE produces no dependence.
8 December Astronomers report in a preprint the possible detection of the earliest first stars, technically referred to as Population III stars. In a paywalled article, American scientists propose policy-based measures to reduce large risks from life sciences research – such as pandemics through accident or misapplication. Risk management measures may include novel international guidelines, effective oversight, improvement of US policies to influence policies globally, and identification of gaps in biosecurity policies along with potential approaches to address them. 9 December Researchers report the development of a blood test, SOBA, for Alzheimer's screening via levels of toxic amyloid beta oligomers with sensitivity and specificity of apparently 99%. On 27 December, a separate study reports another well-performing blood test to detect Alzheimer's disease via biomarker brain-derived tau. Anti-aging research: A study indicates that aging shifts activity toward short genes or shorter transcript length and that this can be countered by interventions. A paywalled study reports higher percentage of daily energy consumption of ultra-processed foods, such as white bread or instant noodles, was associated with faster cognitive decline in aging. Differences can be as large or larger than a 28% faster rate of global cognitive decline (5 Dec). Scientists report that sphingolipids accumulate in muscle during aging whose genetic inhibition or ceramide-blockers such as myriocin could counteract, reducing associated muscle loss (16 Dec).
Sources: en.wikipedia.org
=== Examples of application === The rise of antibiotic resistance poses a serious threat to public health. The presence of antibiotic residues in wastewater exacerbates the problem. SIRIUS identifies and predicts the chemical structures of degradation products created by fungi as a promising biological solution to remove persistent antibiotic residues from wastewater. The widespread use of synthetic polymers in food contact materials have raised significant concerns about plastic contamination in food and beverages. A non-targeted approach to analysis is essential for uncovering both known and unknown contaminants. Researchers screened suspected and unanticipated chemicals in a variety of liquor samples using SIRIUS. SIRIUS is used in forensic science to analyze the chemical changes during decomposition, helping to understand microbial networks and potentially predict the time since death. Neonatal dried blood spots are important for newborn screening and a powerful source for investigating the potential metabolic etiologies of various diseases using untargeted LC-MS-based metabolomics. Researchers used SIRIUS to investigate the stability of metabolites and classes of molecules in neonatal dried blood spot biobanks. Marine microorganisms offer a rich source of bioactive compounds with unique structures and remarkable biological activity. This makes them an important resource for the search for new therapeutic compounds. Researchers are using SIRIUS, to narrow down the search to the most promising microorganisms.
==== Dosage and safety margin ==== The data sheets for meloxicam products for cats also state that: "Meloxicam has a narrow therapeutic safety margin in cats and clinical signs of overdose may be seen at relatively small overdose levels."
=== Propagation === Seeds of A. chilensis germinate without cold stratification. In zones with the possibility of frost, it is recommended to sow in spring in a greenhouse. If they have grown enough, by autumn, the new plants can be planted into individual pots. The potted plants should stay in the greenhouse for the first winter. The following year, after the last expected frost in spring, the plants can be planted out into their final positions. In their first winter outdoors, some type of frost protection is required. For further propagation, vegetative propagation is possible: cuttings of wood with a length of 15 to 30 centimetres (5.9 to 11.8 in) can be planted into pots. These cuttings normally root, and can be planted out in the following spring.
Sources: en.wikipedia.org
== Available forms == DBNPA’s available form is dependent on its intended industrial use. Its pure state is a crystalline solid, with a melting point of 123-126 °C. It is slightly soluble in water (1.5 g per 100 g at 25 °C) but dissolves readily in certain organic solvents like acetone and ethanol. For practical applications, DBPNA is most commonly used in the form of a mixture of 20% active solution combined with water and polyethylene glycol, which enhances its stability and handling in aqueous systems. Its solid forms are also available but are mainly used for packaging and storage; it is often packaged in containers within 25 kg woven bags in order to prevent moisture exposure in storage mechanisms.
=== Solvation effects === Solvation significantly affects the basicity of amines. N−H groups strongly interact with water, especially in ammonium ions. Consequently, the basicity of ammonia is enhanced by 1011 by solvation. The intrinsic basicity of amines, i.e. the situation where solvation is unimportant, has been evaluated in the gas phase. In the gas phase, amines exhibit the basicities predicted from the electron-releasing effects of the organic substituents. Thus tertiary amines are more basic than secondary amines, which are more basic than primary amines, and finally ammonia is least basic. The order of pKb values (basicities in water) does not follow this order. Similarly, aniline is more basic than ammonia in the gas phase, but ten thousand times less so in aqueous solution. In aprotic polar solvents such as DMSO, DMF, and acetonitrile the energy of solvation is not as high as in protic polar solvents like water and methanol. For this reason, the basicity of amines in these aprotic solvents is almost solely governed by the electronic effects.
== Toxicity == The phototoxic effects of bergamot essential oil have been known at least since 1925 when Rosenthal coined the term "Berloque dermatitis" (from the French word "breloque" meaning trinket or charm) to describe the pendant-like streaks of pigmentation observed on the neck, face, and arms of patients. He was unaware that, in 1916, Freund had correctly observed that these pigmentation effects were due to sun exposure after the use of Eau de Cologne, a perfume infused with bergamot oil. Use of bergamot aromatherapy oil, followed by exposure to ultraviolet light (either sunlight or a tanning bed), has been reported to cause phytophotodermatitis, a serious skin inflammation indicated by painful erythema and bullae on exposed areas of the skin. In one case, six drops of bergamot aromatherapy oil in a bath followed by 20–30 minutes exposure of ultraviolet light from a tanning bed caused a severe burn-like reaction.
Three designer NPs have been bioengineered, tested in cell-based assays and animal models of heart failure, undergone pharmaceutical toxicology studies, and have received FDA approval for clinical studies.
Sources: en.wikipedia.org
The principal difference is a chemical cap on the N-terminal tyrosine that prevents rapid enzymatic cleavage. Native GHRH is degraded within minutes in plasma, whereas the modified peptide persists considerably longer. The amino acid backbone otherwise mirrors the natural hormone.
No. It is a receptor agonist that stimulates the pituitary to release endogenous growth hormone. It does not contain or deliver growth hormone. Its downstream effects therefore depend on a functioning pituitary and an intact signaling pathway.
Pituitary responsiveness, receptor availability, and the natural pulsatility of the growth hormone axis all contribute. Because the compound amplifies an existing release pattern rather than overriding it, timing and physiological state matter. Individual variability in response is well documented but not fully explained.
特沙莫瑞林是国际非专利名称，指一种经过 N 端修饰的生长激素释放激素类似物。它被归类为合成肽，序列与 GHRH(1-44) 密切相关。该名称不指代任何特定品牌或剂型。